This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2007 Dec 19;99(24):1823-4.

doi: 10.1093/jnci/djm263. Epub 2007 Dec 11.

Genetic and biologic evidence that implicates a gene in aggressive prostate cancer

Jer-Tsong Hsieh, Jose A Karam, Wang Min

PMID: 18073373
DOI: 10.1093/jnci/djm263

Editorial

Genetic and biologic evidence that implicates a gene in aggressive prostate cancer

Jer-Tsong Hsieh et al. J Natl Cancer Inst. 2007.

. 2007 Dec 19;99(24):1823-4.

doi: 10.1093/jnci/djm263. Epub 2007 Dec 11.

Authors

Jer-Tsong Hsieh, Jose A Karam, Wang Min

PMID: 18073373
DOI: 10.1093/jnci/djm263

No abstract available

PubMed Disclaimer

Comment on

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD. Duggan D, et al. J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. doi: 10.1093/jnci/djm250. Epub 2007 Dec 11. J Natl Cancer Inst. 2007. PMID: 18073375

Similar articles

Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
Duggan D, Zheng SL, Knowlton M, Benitez D, Dimitrov L, Wiklund F, Robbins C, Isaacs SD, Cheng Y, Li G, Sun J, Chang BL, Marovich L, Wiley KE, Bälter K, Stattin P, Adami HO, Gielzak M, Yan G, Sauvageot J, Liu W, Kim JW, Bleecker ER, Meyers DA, Trock BJ, Partin AW, Walsh PC, Isaacs WB, Grönberg H, Xu J, Carpten JD. Duggan D, et al. J Natl Cancer Inst. 2007 Dec 19;99(24):1836-44. doi: 10.1093/jnci/djm250. Epub 2007 Dec 11. J Natl Cancer Inst. 2007. PMID: 18073375
Interactions of PVT1 and CASC11 on Prostate Cancer Risk in African Americans.
Lin HY, Callan CY, Fang Z, Tung HY, Park JY. Lin HY, et al. Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1067-1075. doi: 10.1158/1055-9965.EPI-18-1092. Epub 2019 Mar 26. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30914434 Free PMC article.
Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men.
Bangsi D, Zhou J, Sun Y, Patel NP, Darga LL, Heilbrun LK, Powell IJ, Severson RK, Everson RB. Bangsi D, et al. Urol Oncol. 2006 Jan-Feb;24(1):21-7. doi: 10.1016/j.urolonc.2005.09.005. Urol Oncol. 2006. PMID: 16414488
Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic/biologic mechanism of racial disparity: Update.
Powell IJ, Chinni SR, Reddy SS, Zaslavsky A, Gavande N. Powell IJ, et al. Urol Oncol. 2021 Jan;39(1):34-40. doi: 10.1016/j.urolonc.2020.08.019. Epub 2020 Sep 6. Urol Oncol. 2021. PMID: 32900629 Review.
Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling.
Nwaneri AC, McBeth L, Hinds TD Jr. Nwaneri AC, et al. Horm Cancer. 2016 Dec;7(5-6):296-304. doi: 10.1007/s12672-016-0271-4. Epub 2016 Jul 22. Horm Cancer. 2016. PMID: 27447901 Free PMC article. Review.

See all similar articles

Cited by

AIP1 functions as an endogenous inhibitor of VEGFR2-mediated signaling and inflammatory angiogenesis in mice.
Zhang H, He Y, Dai S, Xu Z, Luo Y, Wan T, Luo D, Jones D, Tang S, Chen H, Sessa WC, Min W. Zhang H, et al. J Clin Invest. 2008 Dec;118(12):3904-16. doi: 10.1172/JCI36168. Epub 2008 Nov 3. J Clin Invest. 2008. PMID: 19033661 Free PMC article.
DAB2IP in cancer.
Liu L, Xu C, Hsieh JT, Gong J, Xie D. Liu L, et al. Oncotarget. 2016 Jan 26;7(4):3766-76. doi: 10.18632/oncotarget.6501. Oncotarget. 2016. PMID: 26658103 Free PMC article. Review.
The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC.
Zhong J, Chaerkady R, Kandasamy K, Gucek M, Cole RN, Pandey A. Zhong J, et al. J Proteomics. 2011 Mar 1;74(3):294-303. doi: 10.1016/j.jprot.2010.11.006. Epub 2010 Nov 13. J Proteomics. 2011. PMID: 21081186 Free PMC article.
The role of homeostatic regulation between tumor suppressor DAB2IP and oncogenic Skp2 in prostate cancer growth.
Tsai YS, Lai CL, Lai CH, Chang KH, Wu K, Tseng SF, Fazli L, Gleave M, Xiao G, Gandee L, Sharifi N, Moro L, Tzai TS, Hsieh JT. Tsai YS, et al. Oncotarget. 2014 Aug 15;5(15):6425-36. doi: 10.18632/oncotarget.2228. Oncotarget. 2014. PMID: 25115390 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal